Parkinsn's Email List Message
Posting to the Parkinsn List is a benefit of Subscription
Re: New Member Introduction - eldepryl
Deanne Charlton wrote: > > In a message dated 97-05-20 07:56:58 EDT, Jim wrote to David: > > << Selegeline Hydrochloride (Eldepryl, et al) can delay Parkinsonian > disability and the need for levodopa therapy by 9-12 months if given in the > early stages. Later, in combination with levodopa, it can reduce levodopa > requirements by 20-50%, and reduce levodopa's side effects. It may have a > neuro-protective effect. One of the side-effects can be insomnia. >> > > For more on eldepryl, its side effects and a different form of it that seems > to have greater positive effects w/ fewer side effects, try www.ceri.com > for their information on PD. > > Deanne Charlton > dcwrites@xxxxxxx Thanks for the not Deanne. Have a good weekend. Best wishes
Parkinsn's Archive Treasures Doctors, students, patients and caregivers find current Parkinson's information such as the Algorithm, Caregivers Handbook, and talks by respected Movement Disorder Specialists.
Mail converted by MHonArc
2.6.10
Site Hosting donated by He.net
&
Grant from The Parkinson Alliance
